Chen, Yi <br/><br/>
Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis.  [electronic resource] 

 -  The Journal of clinical investigation  May 2006 
 - 1317-26 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0021-9738 
<br/><br/><label>Standard No.: </label>10.1172/JCI25308  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Autoimmune Diseases--therapy<br/>Chemokine CXCL10<br/>Chemokines, CXC--metabolism<br/>Disease Models, Animal<br/>Encephalomyelitis--therapy<br/>Female<br/>Inflammation--pathology<br/>Interferon-gamma--metabolism<br/>Interleukin-17--metabolism<br/>Interleukin-23<br/>Interleukin-23 Subunit p19<br/>Interleukin-6--metabolism<br/>Interleukins--immunology<br/>Multiple Sclerosis--therapy<br/>STAT1 Transcription Factor--metabolism<br/>T-Lymphocytes--immunology<br/>Tumor Necrosis Factors--metabolism